Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

AccuRef Diagnostics Emerges as a New Division of Applied StemCell, Inc. With a Focus on Advancing Molecular Diagnostics Through Precision Reference Standards

Applied StemCell,Inc.
Posted on: 08 Nov 17

AccuRef Diagnostics (ARD) is announcing its formation as a new division under Applied StemCell, Inc., an ISO-certified global provider of molecular and cellular reference standards for assay development, proficiency testing, and quality control. The announcement comes as ARD continues to expand its product catalog to generate the largest panel of precision engineered reference standards on the market, with over 215 CRISPR-engineered variants in its oncology catalog, and greater than 1,500 products. “Our ultimate goal is to create a broad portfolio of high value reference standards for routine use on multiple analysis platforms and for multiple clinical diagnostics applications,” said Gianluca Roma, Director of Marketing.

The expanding ARD product catalog provides both singleplex and dPCR pre-validated multiplex reference standards in a diverse set of biorelevant formats, including genomic DNA, FFPE cell blocks, slides and scrolls, as well as matched frozen cell pellets. “Our Onco-Ref™ product series spans everything from a single point mutation to 40+ dPCR pre-validated quantitative multigene panels as part of our Quan-Plex™ product series,” said Dr. Sonika Saddar, Head of Product Development.

In addition to over 1,500 products, the Custom Diagnostics division of ARD partners with pharmaceutical and diagnostics companies to develop custom-engineered variants and pre-validated mutation panels to suit the specific needs of these companies. “Founding of the new AccuRef Diagnostics division emphasizes our commitment to helping advance the molecular diagnostic industry, and strengthens our ongoing partnerships with key diagnostic companies to develop custom reference standard panels,” stated Dr. Ruhong Jiang, President and CEO of Applied StemCell, Inc.

The formation of the division follows on the heels of Applied StemCell’s recent announcement of full ISO 9001 and 13485 certifications at their Milpitas location, which will be inclusive of the newly formed AccuRef Diagnostics division.

About Applied StemCell, Inc.

Applied StemCell, Inc. is a global provider of gene editing and stem cell-based services, as well as a leader in molecular and cellular reference standard products for clinical diagnostics market. For more information, please visit www.appliedstemcell.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171108005263/en/

Business Wire
www.businesswire.com

Last updated on: 08/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.